Point72 Asset Management L.P. acquired a new stake in ICU Medical, Inc. (NASDAQ:ICUI) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 182,610 shares of the medical instruments supplier’s stock, valued at approximately $37,515,000.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of ICUI. Northern Trust Corp raised its stake in ICU Medical by 0.8% in the 4th quarter. Northern Trust Corp now owns 200,294 shares of the medical instruments supplier’s stock valued at $42,961,000 after purchasing an additional 1,628 shares during the last quarter. M&T Bank Corp purchased a new stake in ICU Medical in the 4th quarter valued at $219,000. Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in ICU Medical in the 4th quarter valued at $1,373,000. Credit Suisse AG grew its holdings in ICU Medical by 32.4% in the 4th quarter. Credit Suisse AG now owns 26,972 shares of the medical instruments supplier’s stock valued at $5,786,000 after buying an additional 6,597 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its holdings in ICU Medical by 2.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 153,983 shares of the medical instruments supplier’s stock valued at $33,028,000 after buying an additional 3,353 shares in the last quarter. 94.75% of the stock is owned by hedge funds and other institutional investors.
Separately, Zacks Investment Research upgraded ICU Medical from a “sell” rating to a “hold” rating in a report on Wednesday, April 28th.
ICU Medical (NASDAQ:ICUI) last released its quarterly earnings results on Thursday, May 6th. The medical instruments supplier reported $1.34 earnings per share for the quarter, topping analysts’ consensus estimates of $1.32 by $0.02. The business had revenue of $318.05 million during the quarter, compared to analysts’ expectations of $304.20 million. ICU Medical had a return on equity of 8.69% and a net margin of 7.44%. On average, equities analysts predict that ICU Medical, Inc. will post 6.13 EPS for the current fiscal year.
In other news, VP Virginia Ruth Sanzone sold 983 shares of the stock in a transaction on Tuesday, May 11th. The stock was sold at an average price of $200.11, for a total transaction of $196,708.13. Following the completion of the transaction, the vice president now directly owns 2,405 shares in the company, valued at approximately $481,264.55. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 9.10% of the company’s stock.
ICU Medical Profile
ICU Medical, Inc engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors.
Featured Story: What are economic reports?
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.